Luther King Capital Management (LKCM)
RETA

Luther King Capital Management (LKCM)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-65,534
Closed -$6.68M 615
2023
Q2
$6.68M Hold
65,534
0.03% 177
2023
Q1
$5.96M Hold
65,534
0.03% 176
2022
Q4
$2.49M Hold
65,534
0.01% 277
2022
Q3
$1.65M Hold
65,534
0.01% 306
2022
Q2
$1.99M Sell
65,534
-3,000
-4% -$91.2K 0.01% 296
2022
Q1
$2.25M Sell
68,534
-9,925
-13% -$325K 0.01% 298
2021
Q4
$2.07M Sell
78,459
-36,737
-32% -$969K 0.01% 308
2021
Q3
$11.6M Buy
115,196
+3,325
+3% +$335K 0.06% 139
2021
Q2
$15.8M Buy
111,871
+210
+0.2% +$29.7K 0.08% 129
2021
Q1
$11.1M Buy
111,661
+12,705
+13% +$1.27M 0.06% 141
2020
Q4
$12.2M Buy
98,956
+12,566
+15% +$1.55M 0.07% 132
2020
Q3
$8.42M Buy
86,390
+4,244
+5% +$413K 0.05% 141
2020
Q2
$12.8M Buy
82,146
+16,925
+26% +$2.64M 0.09% 120
2020
Q1
$9.41M Hold
65,221
0.08% 121
2019
Q4
$13.3M Sell
65,221
-41,661
-39% -$8.52M 0.09% 126
2019
Q3
$8.58M Buy
106,882
+7,337
+7% +$589K 0.06% 148
2019
Q2
$9.39M Buy
99,545
+600
+0.6% +$56.6K 0.07% 148
2019
Q1
$8.46M Hold
98,945
0.06% 151
2018
Q4
$5.55M Buy
98,945
+5,429
+6% +$305K 0.05% 164
2018
Q3
$7.65M Hold
93,516
0.06% 156
2018
Q2
$3.27M Buy
93,516
+30,021
+47% +$1.05M 0.03% 229
2018
Q1
$1.3M Buy
63,495
+5,837
+10% +$120K 0.01% 329
2017
Q4
$1.63M Hold
57,658
0.01% 311
2017
Q3
$1.79M Buy
57,658
+1,676
+3% +$52.1K 0.02% 293
2017
Q2
$1.77M Hold
55,982
0.02% 293
2017
Q1
$1.27M Buy
+55,982
New +$1.27M 0.01% 327